Results 151 to 160 of about 15,937 (243)

Effect of bosentan on the production of proinflammatory cytokines in a rat model of emphysema [PDF]

, 2007
Gamze Kılkıl, Mehmet Hamdi Muz, Figen Deveci, Teyfik Turgut, Fulya İlhan, İbrahim Hanifi Özercan   +5 more
openalex   +1 more source

Endothelin B receptor inhibition rescues aging-dependent neuronal regenerative decline. [PDF]

Elife
Feng R, Rosen SF, Ansari I, John S, Thomsen MB, Avraham O, Geoffroy CG, Cavalli V.   +7 more
europepmc   +1 more source

Predicting Food Effect On Oral Drug Absorption For Solubility-Epithelial Membrane Permeation-Limited Cases With Bile Micelle Solubilization. [PDF]

Pharm Res
Higashiguchi Y, Ishida S, Lee S, Sinko B, Box K, Sugano K.   +5 more
europepmc   +1 more source

CLINICAL CASE: COMBINATION THERAPY WITH BOSENTAN AND SILDENAFIL IN THE TREATMENT OF IDIOPATHIC PULMONARY HYPERTENSION

, 2014
Valeriy Bystrov, О А Архипова, T. V. Martynyuk, М. А. Саидова, О. В. Стукалова, N. M. Danilov, Т. А. Сахнова, I. Ye. Chazova   +7 more
openalex   +2 more sources

Bosentan therapy of pulmonary arterial hypertension in connective tissue diseases [PDF]

, 2006
Franco Cozzi, Roberta Montisci, H. Marotta, F. Bobbo, Nadia Durigon, Massimo Ruscazio, Paolo Sfriso, Sabino Iliceto, S. Todesco   +8 more
openalex   +1 more source

Patient-specific and gene-corrected induced pluripotent stem cell-derived endothelial cells elucidate single-cell phenotype of pulmonary veno-occlusive disease. [PDF]

Stem Cell Reports
Ma B, Li T, Li W, Yang H, Zeng Q, Pan Z, Wang K, Chen Q, Xiong C, Zhou Z.   +9 more
europepmc   +1 more source

Endothelin Antagonism with Bosentan: Current Status and Future Perspectives [PDF]

, 2002
Koh Ono, Akira Matsumori
openalex   +1 more source

Treatment recommendations for the systemic pharmacological treatment of systemic sclerosis digital ulcers: Results from the World Scleroderma Foundation Ad Hoc Committee. [PDF]

J Scleroderma Relat Disord
Maltez N, Ross L, Baron M, Alunno A, Campochiaro C, Suliman YA, Schoones JW, Allanore Y, Del Galdo F, Denton CP, Distler O, Frech T, Furst DE, Giuggioli D, Khanna D, Krieg T, Kuwana M, Matucci-Cerinic M, Moinzadeh P, Pope J, Chung L, Hughes M.   +21 more
europepmc   +1 more source

Preparation and physicochemical characterization of spray-dried and jet-milled microparticles containing bosentan hydrate for dry powder inhalation aerosols

, 2016
Hyojung Lee, Ji–Hyun Kang, Honggoo Lee, Dong‐Wook Kim, Yun-Seok Rhee, Ju‐Young Kim, Eun‐Seok Park, Chun‐Woong Park   +7 more
openalex   +2 more sources

Exploring patient preferences regarding the use of combination therapy with endothelin receptor antagonist (ERA) + phosphodiesterase-5 inhibitors (PDE5i). [PDF]

JHLT Open
Kolaitis NA, Kingman M, Wilson M, Rendon GG, Lopez D, Paoli CJ, Rahman M, Martin A, McGarvey N, Lee A, Mirza S, Melendres-Groves L.   +11 more
europepmc   +1 more source